bauer-anythingyoucan-2019.pdf (1.51 MB)
Anything you can do, I can do better: can aptamers replace antibodies in clinical diagnostic applications?
journal contribution
posted on 2019-01-01, 00:00 authored by michelle Bauer, Mia StromMia Strom, David Hammond, Sarah ShigdarSarah ShigdarThe mainstay of clinical diagnostics is the use of specialised ligands that can recognise specific biomarkers relating to pathological changes. While protein antibodies have been utilised in these assays for the last 40 years, they have proven to be unreliable due to a number of reasons. The search for the ‘perfect’ targeting ligand or molecular probe has been slow, though the description of chemical antibodies, also known as aptamers, nearly 30 years ago suggested a replacement reagent. However, uptake has been slow to progress into the clinical environment. In this review, we discuss the issues associated with antibodies and describe some of the applications of aptamers that have relevancy to the clinical diagnostic environment.
History
Journal
MoleculesVolume
24Article number
4377Pagination
1 - 13Publisher
MDPILocation
Basel, SwtizerlandPublisher DOI
Link to full text
ISSN
1420-3049Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Keywords
aptamersantibodiesclinical diagnosticsimmunohistochemistryimmunophenotypinglateral flow devicesScience & TechnologyLife Sciences & BiomedicinePhysical SciencesBiochemistry & Molecular BiologyChemistry, MultidisciplinaryChemistryclinicaldiagnosticsMYCOBACTERIUM-TUBERCULOSISFLOW-CYTOMETRYDNA APTAMERSVALIDATIONSELECTIONTHERAPEUTICSGENERATIONMOLECULESENZYMEASSAYSOrganic Chemistry
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC